European Medicines Agency’s data protection notice for the operation of the Security Access Control System
Agenda - Medicine Shortages (SPOC) Working Party 5 December 2024
Clinical requirements for non replacement therapy in haemophilia A and B - Scientific guideline
Medicine shortage mitigation plan - template
Medicine shortage prevention plan - template
Scintimun-H-C-PSUSA-00000385-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025
Human medicines European public assessment report (EPAR): Bevespi Aerosphere, glycopyrronium,formoterol fumarate dihydrate, Date of authorisation: 18/12/2018, Revision: 8, Status: Authorised
List of substances and products subject to worksharing for signal management
Human medicines European public assessment report (EPAR): Tauvid, Flortaucipir (18F), Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised